Position
Creative Planning in Denali Therapeutics Inc.
Back to the book · All holders of DNLI
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $163.5K$16.51 → $19.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 60.8K | $1M | — | — | — | 0.0% |
| Q1 2026 | 74.1K | $1.42M | $19.20 | $163.5K | $255.4K | 0.0% |